RxDoctor Payments Data

Sarah Bentley

Family · Hendersonville, NCNPI 1548714223

Payments from drug & device makers

$728in general payments, 2019–2025

Across 34 payments — averaging $21.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$202
  • AbbVie$190
  • Bard Peripheral Vascular, Inc.$92
  • Lilly USA, LLC$80
  • Amgen$40
  • Lucid Diagnostics Inc.$33
  • plus $92 from 5 others

What the payments were for

  • Food & beverage$728100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$728 in reported general payments places this provider in the 65th percentile of 4,522 family providers in North Carolina.

See all family providers in North Carolina

Medicare billing

Part B allowed, 2024
$79,791
Medicare patients
164
Services billed
1,216

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban158$116,512
JardianceEmpagliflozin91$67,910
XareltoRivaroxaban89$66,217
OzempicSemaglutide33$54,496
MounjaroTirzepatide34$42,364
ProliaDenosumab15$27,111
FarxigaDapagliflozin Propanediol27$24,795
Risperdal ConstaRisperidone Microspheres11$13,658
EntrestoSacubitril/Valsartan15$12,811
Synjardy XrEmpagliflozin/Metformin Hcl16$12,036
Xigduo XrDapaglifloz Propaned/Metformin18$10,043
Memantine Hcl110$4,697
Atorvastatin Calcium427$4,323
Tresiba Flextouch U-100Insulin Degludec11$4,310
Potassium Chloride126$3,552

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$17$116,512158 claims
Lilly USA, LLCMounjaro$80$42,36434 claims
AmgenProlia$40$27,11115 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 4,522 family providers in North Carolina.

Other family in Hendersonville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →